Skip to content

Therapeutic Effect of Ultrasound-Guided Local Steroid Injection with Hydro-dissection in Carpal Tunnel Syndrome

Effect of Ultrasound-Guided Local Steroid Injection with Hydro-dissection on Symptom Severity, Ultrasound and Nerve Conduction Study of Median Nerve in Carpal Tunnel Syndrome Patients: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014020416485N1
Enrollment
150
Registered
2014-05-04
Start date
2013-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. upper limb mononeuropathy

Interventions

Intervention 1: Injection of 80 mg triamcinolone with 1 ml lidocaine 2% by Hydrodissection method. Intervention 2: Injection of 40 mg triamcinolone with 1 ml distilled water and 1 ml lidocaine 2% by H
Treatment - Other
Rehabilitation
Injection of 80 mg triamcinolone with 1 ml lidocaine 2% by Hydrodissection method
Injection of 40 mg triamcinolone with 1 ml distilled water and 1 ml lidocaine 2% by Hydrodissection method
Injection of 2 ml distilled water and 1 ml lidocaine 2% by Hydrodissection method
Injection of 40 mg triamcinolone without Hydrodissection method
Wrist splinting for 6 weeks

Sponsors

University of Social Welfare and Rehabilitation Sciences (USWR), Deputy of Research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Mild to moderate carpal tunnel syndrome patients with no history of surgical and local steroid injection, without age and gender limitation. Exclusion criteria: Patients with severe carpal tunnel syndrome and severe dysfunction that needs surgical median nerve releasing; patients with history of other therapeutic approaches; history of allergy against steroids or triamcinolone; steroid contraindications; history of cardiac arrhythmia; diabetes mellitus; hand surgeries in past 3 months; Arthritis rheumatoid; cervical radiculopathy; thyroid dysfunctions

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Boston's Questionnaire score. Timepoint: Every two weeks. Method of measurement: Questionnaire score.;Median nerve ultrasound study. Timepoint: Every two weeks. Method of measurement: Diameter and cross section of median nerve.;Median nerve conduction study. Timepoint: Every two weeks. Method of measurement: Motor and sensory latency of median nerve.;Pain Score. Timepoint: Every two weeks. Method of measurement: visual analogue score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Karimi Sari

University of Social Welfare and Rehabilitation Sciences (USWR), Aging Research Center

dr.karimih@yahoo.com+98 21 8126 4354

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026